No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
RGEN241220C110000
- 38.44
- +7.79+25.42%
15min DelayClose Dec 20 16:00 ET
38.44High38.44Low
38.44Open30.65Pre Close1 Volume2 Open Interest110.00Strike Price3.84KTurnover0.00%IV2.76%PremiumDec 20, 2024Expiry Date34.46Intrinsic Value100Multiplier-1DDays to Expiry3.98Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma4.16Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Repligen Corporation (RGEN) Fell Along With Peers
Repligen Initiated at Hold by Canaccord Genuity
Repligen Analyst Ratings
CCORF Initiates Repligen(RGEN.US) With Hold Rating, Announces Target Price $165
Express News | BioLife Solutions Appoints Tony J. Hunt to Its Board of Directors
Press Release: BioLife Solutions Appoints Tony J. Hunt to Its Board of Directors